This webinar aims to explore the transformation of safety teams from reactive cost centers to proactive benefit drivers, emphasizing the importance of providing teams with the right tools & resources to gain actionable insights.
向最优秀的人学习
Join us as our expert speakers share valuable insights and practical knowledge drawn from extensive industry experience.
Country Manager Spain & Head of Global Vigilance Division
Dr. Angel Navarro is the Country Manager of Spain of QbD Group and Head of Vigilance Division. Founder and CEO of Azierta for more than 12 years (Azierta part of QbD Group), his track record endorses him as a strategic leader in the international pharmaceutical sector.
Head Global Business Development Pharma
Dr. Antonio Borregón is the Global Business Development Pharma Head at QbD Group. He has extensive experience in the pharmaceutical field with high-responsibility positions at the international level.
Richard Habis, a PharmD graduate from Saint Joseph University of Beirut, is a **seasoned expert in biopharmaceutical consulting and market research.** With a keen focus on rare diseases and patient-centered care, his expertise extends to leveraging real-world data to drive patient outcomes and healthcare insights. Mr. Habis’s professional journey reflects a strong commitment to integrating patient perspectives in digital health solutions.
继续观看
点播网络研讨会A practical guide for Chinese manufacturers preparing for EU market access. Request the recording to learn how EU-GMP requirements, inspections, and supply chain design impact registration timelines and launch readiness.
立即观看
即将举办的网络研讨会Understand how to translate ERA regulatory expectations into a robust, science-based and submission-ready approach. Learn how to avoid common pitfalls, optimize data requirements and build a defensible Environmental Risk Assessment aligned with current regulatory expectations.
立即注册
点播网络研讨会Deploying AI in a GxP-regulated environment comes with real compliance challenges. In this joint session, QbD Group and delaware cover how to implement AI that is validated, traceable, and inspection-ready. Building on Session 1, this edition opens more time for your questions and live discussion.
立即观看